imatinib mesylate has been researched along with DRESS Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ben-Ami, E; Castells, MC; Connell, NT; Rutherford, AE; Thornton, KA | 1 |
| Aumont, C; Bennaceur-Griscelli, A; Feriel, J; Mathy, V; Petit, M; Sloma, I; Turhan, AG; Vatel, O | 1 |
2 other study(ies) available for imatinib mesylate and DRESS Syndrome
| Article | Year |
|---|---|
Imatinib-induced drug reaction with eosinophilia and systemic symptoms in solid tumors: a patient with dermatofibrosarcoma protuberans and successful desensitization management.
Topics: Adult; Antineoplastic Agents; Dermatofibrosarcoma; Desensitization, Immunologic; Dose-Response Relationship, Drug; Drug Hypersensitivity Syndrome; Humans; Imatinib Mesylate; Male; Prednisone; Skin Neoplasms | 2018 |
Drug reaction with eosinophilia and systemic symptoms (DRESS) induced by imatinib in chronic myeloid leukemia.
Topics: Antineoplastic Agents; Blood Cell Count; Drug Hypersensitivity Syndrome; Drug Substitution; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Protein Kinase Inhibitors; Skin; Treatment Outcome | 2017 |